Potential adverse effects associated with inhibition of p38α/β MAP kinases

Current Topics in Medicinal Chemistry

Volumn 5, Issue 10, 2005, Pages 929-939

  Dambach, Donna M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; 5 (2,6 DICHLOROPHENYL) 2 (2,4 DIFLUOROPHENYLTHIO)PYRIMIDO[1,6 B]PYRIDAZIN 6 ONE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; DORAMAPIMOD; ETANERCEPT; IBUPROFEN; INFLIXIMAB; ISOENZYME; LIVER ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MYOCYTE ENHANCER FACTOR 2; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; ROFECOXIB; SCIO 469; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE ANTIGEN; THROMBOXANE A2; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; VX 702;

BLOOD TOXICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; DIZZINESS; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TARGETING; ENZYME ACTIVITY; FETUS DEVELOPMENT; HEART DISEASE; HEART INFARCTION; HEMATOPOIESIS; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; INFLAMMATION; LIVER DYSFUNCTION; MALIGNANT NEOPLASTIC DISEASE; MUSCLE DEVELOPMENT; NEUROTOXICITY; NONHUMAN; PERINATAL DEVELOPMENT; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; STROKE; THROMBOEMBOLISM;

ANIMALS; BLOOD COAGULATION; ENZYME INHIBITORS; HEART; HEMATOPOIESIS; HUMANS; IMMUNE SYSTEM; LIVER; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 11; MITOGEN-ACTIVATED PROTEIN KINASE 14; MUSCLE, SKELETAL; NERVOUS SYSTEM; PROTEIN ISOFORMS; REPRODUCTION; TISSUE DISTRIBUTION;

EID: 27744522930     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026054985911     Document Type: Review

References (145)

1. Dinarello, C. A. Inflammatory Cytokines: Interleukin-1 and Tumor Necrosis Factor as Effector Molecules in Autoimmune Diseases. Curr. Opin. Immunol. 1991, 3, 941-948.
2. Feldman, M.; Brennan, F. M.; Maini, R. N. Role of Cytokines in Rheumatoid Arthritis. Annu. Rev. Immunol. 1996, 14, 397-440.
3. Rankin, E. C.; Choy, E. H.; Kassimos, D.; Kingsley, G. H.; Sopwith, A. M.; Isenberg, D. A.; Panayi, G. S. The Therapeutic Effects of an Engineered Human Anti-Tumor Necrosis Factor Alpha Antibody (CDP571) in Rheumatoid Arthritis. Br. J. Rheumatol. 1995, 34, 334-342.
4. Present, D. H.; Rutgeerts, P.; Targan, S.; Hanauer, S. B.; Mayer, L.; van Hogezand, R. A.; Podolsky, D. K.; Sands, B. E.; Braakman, T.; DeWoody, K. L.; Schaible, T. F.; van Deventer, S. J. Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease. N. Engl. J. Med. 1999, 340, 1398-1405.
5. Jarvis, B.; Faulds, D. Enanercept: a Review of its Use in Rheumatoid Arthritis. Drugs 1999, 57, 945-966.
6. Mease, P. J.; Goffe, B. S.; Metz, J.; VanderStoep, A.; Finck, B.; Burge, D. J. Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis: a Randomized Trial. Lancet 2000, 356, 385-390.
7. Bresnihan, B. The Prospect of Treating Rheumatoid Arthritis with Recombinant Human Interleukin-1 Receptor Antagonist. BioDrugs 2001, 15, 87-97.
8. Lee, J. C.; Laydon, J. T.; McDonnell, P. C.; Gallagher, T. F.; Kumar, S.; Green, D.; McNutty, D.; Blumenthal, M. J.; Heys, J. R.; Landvatter, S. W.; strickler, J. E.; McLaughlin, M. M.; Siemens, I. R.; Fisher, S. M.; Livi, G. P.; White, J. R.; Adams, J. L.; Young, P. R. A Protein Kinase Involved in the Regulation of Inflammatory Cytokine Biosynthesis. Nature 1994, 372, 739-746.
9. Ono, K.; Han, J. The P38 Signal Transduction Pathway: Activation And Function. Cell Signal. 2000, 12, 1-13.
10. Lee, J. C.; Kumar, S.; Griswold, D. E.; Underwood, D. C; Votta, B. J.; Adams, J. L. Inhibition of p38 MAP Kinase as a Therapeutic Strategy. Immunopharmacol. 2000, 47, 185-201.
11. Baldassare, J. J.; Bi, Y.; Bellone, C. J. The Role Of P38 Mitogen-Activated Protein Kinase In IL-1 Beta Transcription. J. Immunol. 1999, 162, 5367-5373.
12. Brook, M,; Sully, G.; Clark, A. R.; Saklatvala, J. Regulation of Tumor Necrosis Factor Alpha mRNA Stability by the Mitogen-Activated Protein Kinase p38 Signalling Cascade. FEBS Lett. 2000, 483, 57-61.
13. Prichett, W.; Hand, A.; Sheilds, J.; Dunnington, D. Mechanism of Action of Bicyclic Imidazoles Defines a Translational Regulatory Pathway for Tumor Necrosis Signalling Cascade. J. Inflam. 1995, 45, 97-105.
14. Clark, A. R.; Dean, J. L. E.; Saklatvala, J. Post-Transcriptional Regulation of Gene Expression by Mitogen-Activated Protein Kinase p38. FEBS Lett. 2003, 546, 37-44.
15. Cirillo, P. F.; Pargellis, C.; Regan, J. The Non-Diaryl Heterocycle Classess Of P38 MAP Kinase Inhibitors. Cur. Top. Med. Chem. 2002, 2, 1021-1035.
16. Saurin, A. T.; Martin, J. L.; Heads, R. J.; Foley, C.; Mockridge, J. W.; Wright, M. J.; Wang, Y.; Marber, M. S. The Role of differential Activation of p38-Mitogen-Activated Protein Kinase in Preconditioned Ventricular Myocytes. FASEB J. 2000, 14, 2237-2246.
17. Fijen, J. W.; Zijlstra, J. G.; De Boer, P.; Spangersberg, R.; Cohen Tervaert, J. W.; Van Der Werf, T. S.; Ligtenberg, J. J.; Tukkeken, J. E. Suppression of the Clinical and Cytokine Response to Endotoxin by RWJ-67657, a p38 Mitogen-Activated Protein-Kinase Inhibitor, in Healthy Human Volunteers. Clin. Exp. Immunol. 2001, 124, 16-20.
18. Behr, T. M.; Berova, M.; Doe, C. P.; Ju, H,; Angermann, C. E.; Boehm, J.; Willette, R. N. p38 Mitogen-Activated Protein Kinase Inhibitors for the Treatment of Chronic Cardiovascular Disease. Curr. Opin. Invest. Drugs 2003, 4, 1059-1064.
19. Kyriakis, J. M.; Avruch, J. Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated By Stress And Inflammation. Physiol. Rev. 2001, 807-869.
20. Tibbles, L. A.; Woodgett, J. R. The Stress-Activated Protein Kinase Pathways. Cell Mol. Life Sci. 1999, 55, 1230-1254.
21. Chang, L.; Karin, M. Mammalian MAP Kinase Signalling Cascades. Nature 2001, 410, 37-40.
22. Martin-Blanco, E. P38 MAPK Signalling Cascades: Ancient Roles And New Functions. BioEssays 2000, 22, 637-645.
23. Fabian, M. A.; Biggs III, W. H.; Treiber, D. K.; Atteridge, C. E.; Azimioara, M. D.; Benedetti, M. G.; Carter, T. A.; Ciceri, P.; Edeen, P. T.; Floyd, M.; Ford, J. M.; Galvin, M.; Gerlach, J. L.; Grotzfeld, R. M.; Herrgard, S.; Insko, D. E.; Insko, M. A.; Lai, A. G.; Lélias, J- M.; Mehta, S. A.; Milanov, Z.; Velasco, A. M.; Wodicka, L. M.; Patel, H. K.; Zarrinkar, P. P.; Lockhart, D. L. A Small Molecule Kinase Interaction Map For Clinical Kinase Inhibitors. Nature Biotechnol. 2005, 23, 329-336.
24. Scios-469 Drug Report. Investig. Drugs Database 2004, #407933.
25. Cuenda A.; Cohen P.; Buée-Scherrer, V.; Goedert, M. Activation Of Stress-Activated Protein Kinase-3 (SAPK3) By Cytokines And Cellular Stresses Is Mediated Via SAPKK3 (MKK6); Comparison Of The Specificities Of SAPK3 And SAPK2 (RK/P38). EMBO J. 1997, 1, 295-305.
26. Jiang, Y.; Chen, C.; Li, Z.; Gue, W.; Genger, J.; Lin, S.; Hann, J. Characterization Of The Structure And Function Of A New Mitogen-Activated Protein Kinase (P38β). J. Biol. Chem. 1996, 271, 17920-17926.
27. Wang, X. S.; Diener, K.; Manthey, C. L.; Wang, S.; Rosenzweig, B.; Bray, J.; Delaney, J.; Cole, C. N.; Chan-Hui, P- Y.; Mantlo, N.; Lichenstein, H. S.; Zukowski, Z.; Yao, Z. Molecular Cloning And Characterization Of A Novel P38 Mitogen-Activated Protein Kinase. J. Biol. Chem. 1997, 27, 23668-23674.
28. Enslen, H.; Raingeaud, J.; Davis, R. J. Selective Activation Of P38 Mitogen-Activated Protein (MAP) Kinase Isoforms By The MAP Kinase Kinases MKK3 And MKK6. J. Biol. Chem. 1998, 273, 1741-1748.
29. Enslen, H.; Brancho, D. M.; Davis, R. J. Molecular Determinants That Mediate Selective Activation Of P38 MAP Kinase Isoforms. EMBO J. 2000, 19, 1301-1311.
30. Knebel, A.; Haydon, C. E.; Morrice, N.; Cohen, P. Stress-Induced Regulation Of Eukaryotic Elongation Factor 2 Kinase By SB 203580-Sensitive And -Insensitive Pathways. Biochem. J. 2002, 367, 525-532.
31. Jiang, Y.; Gram, H.; Zhao, M.; New, L.; Gu, J.; Feng, L.; DiPadova, F.; Ulevitch, R. J.; Han, J. Characterization Of The Structure And Function Of The Fourth Member Of P38 Group Mitogen-Activated Protein Kinases, P38δ. J. Biol. Chem. 1997, 271, 30122-128.
32. Hate, K. K.; Trollinger, D.; Rihanek, M.; Manthey, C. L. Differential Expression And Activation Of P38 Mitogen-Activated Protein Kinase Alpha, Beta, Gamma, And Delta In Inflammatory Cell Lineages. J. Immunol. 1999, 162, 4246-4252.
33. Li, Z.; Jiang, Y.; Ulevitch, R. J.; Han, J. The Primary Structure Of P38γ: A New Member Of The P38 Group Of MAP Kinases. Biochem. Biophys. Res. Comm. 1996, 228, 334-340.
34. Lechner, C.; Zahalka, M. A.; Griot, J- F.; Moller, N. P. H.; Ulrich, A. ERK6, A Mitogen-Activated Protein Kinase Involved In C2C12 Myoblast Differentiation. Proc. Natl. Acad. Sci. 1996, 93, 4355-4359.
35. Court, N. W.; dos Remedios, C. G.; Cordell, J.; Bogoyevitch, M. A. Cardiac Expression And Subcellular Localization Of The P38 Mitogen-Activated Protein Kinase Member, Stress-Activated Kinase-3 (SAPK3). J. Mol. Cell. Cardiol. 2002, 34, 413-426.
36. Tortotella, L. L.; Lin, C. B.; Pilch, P. F. ERK6 Is Expressed In A Developmentally Regulated Manner In Rodent Skeletal Muscle. Biochem. Biophys. Res. Comm. 2003, 306, 163-168.
37. Hasegawa, M.; Cuenda, A.; Spillantini, M. G.; Thomas, G. M.; Buee-Scherrer, V.; Cohen, P.; Goedert, M. Stress-Activated Protein Kinase-3 Interacts With The PDZ Domain Of Alpha 1-Syntrophin. A Mechanism For Specific Substrate Recognition. J. Biol. Chem. 1999, 274, 12626-12631.
38. Sabio, G.; Reuver, S.; Feijoo, C.; Hasegawa, M.; Thomas, G. M.; Centeno, F.; Kuhlendahl S.; Leal-Ortiz, S.; Goedert, M.; Garner, C.; Cuenda, A. Stress- And Mitogen-Induced Phosphorylation Of The Synapse-Associated Protein SAP90/PSD-95 By Activation Of SAPK3/P38gamma And ERK1/ERK2. Biochem. J. 2004, 380, 19-30.
39. Ho, R. C.; Alcazar, O.; Fujii, N.; Hirshman, M. F.; Goodyear, L. J. P38gamma MAPK Regulation Of Glucose Transporter Expression And Glucose Uptake In L6 Myotubes And Mouse Skeletal Muscle. Am. J. Physiol. 2004, 28, R342-R349.
40. Kumar, S.; McDonnell, P. C.; Gum, R. J.; Hand, A. T.; Lee, J. C.; Young, P. R. 1997. Novel Homologues Of CSBP/P38 MAP Kinase: Activation, Substrate Specificity And Sensitivity To Inhibition By Pyridinyl Imidazoles. Biochem. Biophys. Res. Comm. 1997, 235, 533-538.
41. Eckert, R. L.; Efimova, T.; Balasubramanian, S.; Crish, J. F.; Bone, F.; Dashti, S. P38 Mitogen-Activated Protein Kinases On The Body Surface-A Function For P38δ. J. Invest. Dermatol. 2003, 120, 823-828.
42. Feijoo C.; Campbell D. G.; Jakes R.; Goedert M.; Cuenda, A. Evidence That Phosphorylation Of The Microtubule-Associated Protein Tau By SAPK4/P38delta At Thr50 Promotes Microtubule Assembly. J. Cell. Sci. 2005, 118, 397-408.
43. Liang, Q.; Molkentin, J. D. Redefining The Roles Of P38 And JNK Signaling In Cardiac Hypertrophy: Dichotomy Between Cultured Myocytes And Animal Models. J. Mol. Cell. Cardiol. 2003, 35, 1385-1394.
44. Sabio, G,; Arthur, J. S.; Kuma, Y.; Peggie, M.; Carr, J.; Murray-Tait, V.; Centeno, F.; Goedert, M.; Morrice, N. A.; Cuenda, A. P38gamma Regulates The Localisation Of SAP97 In The Cytoskeleton By Modulating Its Interaction With GKAP. EMBO J. 2005, 24, 1134-1145.
45. Adams, R. H.; Porras, A.; Alonso, G.; Jones, M.; Vintersten, K.; Panelli, S.; Valladares, A.; Perez, L.; Klein, R.; Nebreda, A. R. Essential Role Of P38α MAP Kinase In Placenta But Not Embyronic Cardiovascular Development. Mol. Cell 2000, 6, 109-116.
46. Allen, M.; Svensson, L. Deficiency Of The Stress Kinase 38alpha Results In Embryonic Lethality: Characterization Of The Kinase Dependence Of Stress Responses Of Enzyme-Deficient Embryonic Stem Cells. J. Exp. Med. 2000, 191, 859-870.
47. Mudgett, J. S.; Ding, J.; Guh-Siesel, L.; Chartrain, N. A.; Yang, L.; Gopal, S.; Shen M. M. Essential Role For P38alpha Mitogen-Activated Protein Kinase In Placental Angiogenesis. Proc. Natl. Acad. Sci. 2000, 97, 10454-10459.
48. Tamura, K.; Sudo, T.; Senftleben, U.; Dadak, A. M.; Johnson, R.; Karin, M. Requirement For P38alpha In Erythropoietin Expression: A Role For Stress Kinases In Erythropoiesis. Cell 2000, 102, 221-231.
49. Otsu, K.; Yamashita, N.; Nishida, K.; Hirotani, S.; Yamaguchi, O.; Watanabe, T.; Hikoso, S.; Higuchi, Y.; Matsumura, Y.; Maruyama, M.; Sudo, T.; Osada, H.; Hori, M. Disruption Of A Single Copy Of The P38alpha MAP Kinase Gene Leads To Cardioprotection Against Ischemia-reperfusion. Biochem. Biophys. Res. Comm. 2003, 302, 56-60.
50. Branger, J.; van den Blink, B.; Weijer, S.; Madwed, J.; Bos, C. L.; Gupta, A.; Yong, C- L.; Polmar, S. H.; Olszyna, D. P.; Hack, C. E.; van Deventer, S. J. H.; Peppelenbosch, M. P.; van der Poll, T. 2002. Anti-Inflammatory Effects Of A P38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia. J. Immunol. 2002, 168, 4070-4077.
51. Van den Blink, B.; Juffermans, N. P.; ten Hove, T.; Schultz, M. J.; van Deventer, S. J. H.; van der Poll, T.; Peppelenbosch, M. P. 2001. P38 Mitogen-Activated Protein Kinase Inhibition Increases Cytokine Release By Macrophages In Vitro And During Infection In Vivo. J. Immunol. 2001, 166, 582-587.
52. Lehner, M. D.; Schwoebel, F.; Kotlyarov, A.; Leist, M.; Gaestel, M.; Hartung, T. Mitogen-Activated Protein Kinase-Activated Protein Kinase-2 Deficient Mice Show Increased Susceptibility To Listeria monocytogenes Infection. J. Immunol. 2002, 168, 4667-4673.
53. Platanias, L. C. 2003. The P38 Mitogen-Activated Protein Kinase Pathway And Its Role In Interferon Signaling. Pharmacol. Ther. 2003, 98, 129-142.
54. Culy, C. R.; Keating, G. M. 2003. Spotlight On Etanercept In Rheumatoid Arthritis, Psoriatic Arthritis, And Juvenile Rheumatoid Arthritis. BioDrugs 2003, 17, 139-145.
55. Kavanaugh, A.; Cush, J. J. FDA Meeting: Update On The Safety Of New Drugs For Rheumatoid Arthritis. Part II: CHF, Infection, And Other Safety Issues. Hotline August 2003, www.rheumatology.org/publications/hotline.
56. Ricon, M.; Pedraza-Alva, G. JNK and p38 MAP Kinases in CD4+ and CD8+ T cells. Immunol. Rev. 2003, 192, 131-142.
57. Nebreda, A. R.; Porras, A. P38 MAP Kinases: Beyond The Stress Response. Trends Biochem. Sci. 2000, 25, 257-260.
58. Hu, M. C.; Wang, Y. P.; Mikhail, A.; Qiu, W. R.; Tan, T. H. Murine P38-Delta Mitogen-Activated Protein Kinase, A Developmentally Regulated Protein Kinase That Is Activated By Stress And Proinflammatory Cytokines. J. Bio. Chem. 1999, 274, 7095-7102.
59. Awazu, M.; Omori, S.; Hilda, M. MAP Kinases In Renal Development. Nephrol. Dial. Transplant 2002, 17 Suppl, 5-7.
60. Hida, M.; Omori, S.; Awazu, M. ERK And P38 MAP Kinase Are Required For Rat Renal Development. Kidney Int. 2002, 61, 1252-1262.
61. Zhen, X.; Wei, L.; Wu, Q.; Zhang, Y.; Chen, Q. Mitogen-Activated Protein Kinase P38 Mediates Regulation Of Chrondrocyte Differentiation By Parathyroid Hormone. J. Bio. Chem. 2001, 272, 4879-4885.
62. Guicheux, J.; Lemonnier, J.; Ghayor, C.; Suzuki, A.; Palmer, G.; Caverzasio, J. Activation Of P38 Mitogen-Activated Protein Kinase And C-Jun-NH2-Terminal Kinase By BMP2 And Their Implication In The Stimulation Of Osteoblastic Cell Differentiation. J. Bone Miner. Res. 2003, 18, 2060-2068.
63. Centrella, M.; McCarthy, T. L.; Canalis, E. Mitogenesis In Fetal Rat Bone Cells Simultaneously Exposed To Type Beta Transforming Growth Factor And Other Growth Regulators. FASEB J. 1987, 1, 312-317.
64. Wride, M. A.; Sanders, E. J. Potential Roles For Tumor Necrosis Factor Alpha During Embryonic Development. Anal. Embryol. 1995, 191, 1-10.
65. Hill, J. A. Cytokines Considered Critical In Pregnancy. Am. J. Reprod. Immunol. 1992, 28, 123-126.
66. Tabibzadeh, S. Molecular Control Of The Implantation Window. Hum. Reprod. Update 1998, 4, 465-471.
67. Hill, J. A.; Choi, B. C. Maternal Immunological Aspects Of Pregnancy Success And Failure. J. Reprod. Fertil. Suppl. 2000, 55, 91-97.
68. Todt, J. C.; Yang, Y.; Lei, J.; Lauria, M. R.; Sorokin, Y.; Cotton, D. B.; Yelian, F. D. Effects Of Tumor Necrosis Factor-Alpha On Human Trophoblast Cell Adhesion And Motility. Am. J. Repro. Immunol. 1996, 36, 65-71.
69. Sugden, P. H.; Clerk, A. "Stress-Responsive" Mitogen-Activated Protein Kinases (C-Jun N-Terminal Kinases And P38 Mitogen-Activated Protein Kinases) In The Myocardium. Circ. Res. 1998, 83, 345-352.
70. Ravingerova, T.; Barancik, M.; Strniskova, M. Mitogen-Activated Protein Kinases: A New Therapeutic Target In Cardiac Pathology. Mol. Cell. Biochem. 2003, 247, 127-138.
71. Ma, X. L.; Kumar, S.; Gao, F.; Louden, C. S.; Lopez, B. L.; Christopher, T. A.; Wang, C.; Lee, J. C.; Feuerstain, G. Z.; Yoe, T- L. Inhibition Of P38 Mitogen-Activated Protein Kinase Decreases Cardiomyocyte Apoptosis And Improves Cardiac Function After Myocardial Ischemia And Reperfusion. Circulation 1999, 99, 1685-1691.
72. Lemke, L. E.; Bloem, L. J.; Fouts, R.; Esterman, M.; Sandusky, G.; Vlahos, C. J. Decreased P38 MAPK Activity In End-Stage Failing Human Myocardium: P38 MAPK Alpha Is The Predominant Isoform Expressed In Human Heart. J. Mol. Cell. Cardiol. 2001, 33, 1527-1540.
73. Haq, S.; Choukroun, G.; Lim, H. W.; Tymitz, K. M.; del Monte, F.; Gwathmey, J. K.; Grazette, L.; Michael, A.; Hajjar, R.; Force, T.; Molkentin, J. D. Differential Activation Of Signal Transduction Pathways In Human Hearts With Hypertrophy Versus Advanced Heart Failure. Circulation 2001, 103, 670-677.
74. Zechner, D.; Thuerauf, D. J.; Hanford, D. J.; McDonough, P. M.; Glembotski, C. C. A Role For The P38 Mitogen-Activated Protein Kinase Pathway In Myocardial Cell Growth, Sarcomeric Organization, And Cardiac-Specific Gene Expression. J. Cell. Biol. 1997, 139, 115-127.
75. Wang, Y.; Su, B.; Sah, V. P.; Brown, J. H.; Han, J.; Chien, K. R. Cardiac Hypertrophy Induced By Mitogen-Activated Protein Kinase Kinase 7, A Specific Activator For C-Jun NH2-Terminal Kinase In Ventricular Muscle Cells. J. Biol. Chem. 1998, 273, 5423-5426.
76. Engel, F. B.; Schebesta, M.; Duong, M. T.; Lu, G.; Ren, S.; Madwed, J. B.; Jiang, H.; Wang, Y.; Keating, M. T. p38 MAP Kinase Inhibition Enables Proliferation of Adult Mammalian Cardiomyocytes. Genes Develop. 2005, 19, 1175-1187.
77. Choukroun, G.; Hajjar, R.; Kyriakis, J. M.; Bonventre, J. V.; Rosenzweig, A.; Force, T. Role Of The Stress-Activated Protein Kinases In Endothelin-Induced Cardiomyocyte Hypertrophy. J. Clin. Invest. 1998, 102, 1311-1320.
78. Clerk, A.; Michael, A.; Sugden, P. H. Stimulation Of The P38 Mitogen-Activated Protein Kinase Pathway In Neonatal Ventricular Myocytes By The G Protein-Coupled Receptor Agonists, Endothelin-1 And Phenylepherine: A Role For Cardiac Myocyte Hypertrophy? J. Cell. Biol. 1998, 142, 523-535.
79. Ng, D. C.; Long, C. S.; Bogoyevitch, M. A. A Role For The Extracellular Signal-Regulated Kinase And P38 Mitogen-Activated Protein Kinases In Interleukin-1 Beta-Stimulated Delayed Signal Transducer And Activator Of Transcription 3 Activation, Atrial Natriuretic Factor Expression, And Cardiac Myocyte Morphology. J. Biol. Chem. 2000, 276, 29490-29498.
80. Kolodziejczyk, S. M.; Wang, L.; Balazsi, K.; DeRepentigny, Y.; Kothary, R.; Megeney, L. A. MEF2 Is Upregulated During Cardiac Hypertrophy And Is Required For Normal Post-Natal Growth Of The Myocardium. Current Biol. 1999, 9, 1203-1206.
81. Wang, Y. Signal Transduction In Cardiac Hypertrophy-Dissecting Compensatory Versus Pathological Pathways Utilizing A Transgenic Approach. Cur. Opin. Pharmacol. 2001, 1, 134-140.
82. Liao, P.; Georgakopoulos, D.; Kovacs, A.; Zheng, M.; Lerner, D.; Pu, H.; Safftiz, J.; Chien, K.; Xiao, R- P.; Kass, D. A.; Wang, Y. In Vivo Role Of P38 MAP Kinases In Cardiac Remodeling And Restrictive Cardiomyopathy. Proc. Natl. Acad. Sci. 2001, 98, 12283-12288.
83. Braz, J. C.; Bueno, O. R.; Liang, Q.; Wilkins, B. J.; Dai, Y- S.; Parsons, S.; Braunwart, J.; Glascock, B. J.; Klevitsky, R.; Kimball, T. F.; Hewett, T. E.; Molkentin, J. D. Targeted Inhibition Of P38 MAPK Promotes Hypertrophic Cardiomyopathy Through Upregulation Of Calcineurin-NFAT Signaling. J. Clin. Invest. 2003, 111, 1475-1486.
84. Zhang, S.; Weinheimer, C.; Courtois, M.; Kovacs, A.; Zhang, C. E.; Cheng, A. M.; Wang, Y.; Muslin, A. J. The Role Of The Grb-2-P38 MAPK Signaling Pathway In Cardiac Hypertrophy And Fibrosis. J. Clin. Invest. 2003, 111:833-841.
85. Chen, Q. M.; Tu, V. C.; Purdom, S.; Wood, J.; Dilley, T. Molecular Mechanisms Of Cardiac Hypertrophy Induced By Toxicants. Cardiovasc. Tox. 2001, 1, 267-283.
86. Hoefen, R. J.; Berk, B. C. The Role Of MAP Kinases In Endothelial Activation. Vasc. Pharmacol. 2001, 38, 271-273.
87. Bueno, O. F.; Molkentin, J. D. Involvement Of Extracellular Signal-Regulated Kinases 1/2 In Cardiac Hypertrophy And Cell Death. Circ. Res. 2002, 91, 776-781.
88. Tenhunen, O.; Samian, B.; Kerkela, R.; Szokodi, I.; Papp, L.; Toth, M.; Ruskoaho, H. Mitogen-Activated Protein Kinases P38 And ERK 1/2 Mediate The Wall Stress-Induced Activation Of GATA-4 Binding In Adult Heart. J. Biol. Chem. 2004, 279, 24852-24860.
89. Molkentin, J. D. The Zinc Finger-Containing Transcription Factors GATA-4, -5, And -6: Ubiquitously Expressed Regulators Of Tissue-Specific Gene Expression. J. Biol. Chem. 2000, 275, 13721-13726.
90. Saklatvala, J.; Rawlinson, L.; Waller, R. J.; Sarsfield, S.; Lee, J. C.; Morton, L. F.; Barnes, M. J.; Farndale, R. W. Role Of P38 Mitogen-Activated Protein Kinase In Platelet Aggregation Caused By Collagen Or A Thromboxane Analogue. J. Biol. Chem. 1996, 271, 6586-6589.
91. Borsch-Haubold, A. G.; Ghomashchi, F.; Pasquet, S.; Goedert, M.; Cohen, P.; Gelb, M. H.; Watson, S. P. Phosphorylation Of Cytosolic Phospholipase A2 In Platelets Is Mediated By Multiple Stress-Activated Protein Kinase Pathways. Eur. J. Biochem. 1999, 265, 195-203.
92. Branger, J.; van den Blink, B.; Weijer, S.; Gupta, A.; van Deventer, J. H.; Hack, C. E.; Peppelenbosch, M. P.; van der Poll, T. Inhibition Of Coagulation, Fibrinolysis, And Endothelial Cell Activation By P38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia. Blood 2003, 101, 4446-4448.
93. Skalatvala, J. The P38 MAP Kinase Pathway As A Therapeutic Target In Inflammatory Disease, Curr. Opin. Pharmacol. 2004, 4, 372-377.
94. Sakurai, K.; Matsuo, Y.; Sudo, T.; Takuwa, Y.; Kimura, S.; Kasuya, Y. Role Of P38 Mitogen-Activated Protein Kinase In Thrombus Formation. J. Recept. Signal Trans. 2004, 24, 283-296.
95. Chun, K. S.; Surh, Y. J. Signal Transduction Pathways Regulating Cyclooxygenase-2 Expression: Potential Molecular Targets For Chemoprevention. Biochem. Pharmacol. 2004, 68, 1089-1100.
96. Westra, J.; Doornbos-van der Meer, B.; de Boer, P.; van Leeuwen, M. A.; van Rijswijk, M. H.; Limburg, P. C. Strong Inhibition Of TNF-Alpha Production And Inhibition Of IL-8 And COX-2 Mrna Expression In Monocyte-Derived Macrophages By RWJ 67657, A P38 Mitogen-Activated Protein Kinase (MAPK) Inhibitor. Arthritis Res. Ther. 2004, 6, R384-92.
97. de Gaetano, G.; Donati, M. B.; Cerletti, C. Prevention Of Thrombosis And Vascular Inflammation: Benefits And Limitations Of Selective Or Combined COX-1, COX-2 And 5-LOX Inhibitors. Trends Pharmacol. Sci. 2003, 24, 245-252.
98. Cheng, Y.; Austin, S. C.; Rocca, B.; Koller, B. H.; Coffman, T. M.; Grosser, T.; Lawson, J. A.; FitzGerald, G. A. Role Of Prostacyclin In The Cardiovascular Response To Thromboxane A2. Science 2002, 296, 539-541.
99. FitzGerald, G. A. Coxibs And Cardiovascular Disease. N. Engl. J. Med. 2004, 351, 1709-1711.
100. FitzGerald, G. A. Cox-2 And Beyond: Approaches To Prostaglandin Inhibition In Human Disease. Nature Rev. 2003, 2, 879-899.
101. Catella-Lawson, F.; Crofford, L. J. Cyclooxygenase Inhibition And Thrombogenicity. Am. J. Med. 2001, 110:28S-32S.
102. Mukherjee, D. Selective Cyclooxygenase-2 (COX-2) Inhibitors And Potential Risk Of Cardiovascular Events. Biochem. Pharmacol. 2003, 63, 817-821.
103. Weir, M. R.; Sperling, R. S.; Reicin, A.; Gertz, B. J. Selective Cox-2 Inhibition And Cardiovascular Effects: A Review Of The Rofecoxib Development Program. Am. Heart J. 2003, 146, 591-604.
104. Egan, K. M.; Lawson, J. A.; Fries, S.; Koller, B.; Rader, D. J.; Smyth, E. M.; FitzGerald, G. A. COX-2-Derived Prostacyclin Confers Atheroprotection On Female Mice. Science 2004, 306, 1954-1957.
105. Behr, T. M.; Nerurkar, S. S.; Nelson, A. H.; Coatney, R. W.; Woods, T. N.; Sulpizio, A.; Chandra, S.; Brooks, D. P.; Kumar, S.; Lee, J. C.; Ohlstein, E. H.; Angermann, C. E.; Adams, J. L.; Sisko, J.; Sackner-Bernstein, J. D.; Willette, R. N. Hypertensive End-Organ Damage And Premature Mortality Are P38 Mitogen-Activated Protein Kinase-Dependent In A Rat Model Of Cardiac Hypertrophy And Dysfunction. Circulation 2001, 104, 1292-1298.
106. DeMaria, A. N. Relative Risk Of Cardiovascular Events In Patients Wih Rheumatoid Arthritis. Am. J. Cardiol. 2002, 89 Suppl, 33D-38D.
107. Lim, M. Y.; Wang, H.; Kapoun, A. M.; OConnell, M.; O'Young, G.; Brauer, H. A.; Luedtke, G. R.; Chakravarty, S.; Dugar, S.; Schreiner, G. S.; Protter, A. A.; Higgins, L. S. P38 Inhibition Attenuates The Pro-Inflammatory Response To C-Reactive Protein By Human Peripheral Blood Mononuclear Cells. J. Mol. Cell. Cardiol. 2004, 37, 1111-1114.
108. Kher, N.; Marsh, J. D. Pathobiology Of Atherosclerosis: A Brief Review. Seminar. Thromb. Hemostas. 2004, 30, 665-672.
109. Traub, O.; Berk, B. C. Laminar Shear Stress: Mechanisms By Which Endothelial Cells Transduce An Atheroprotective Force. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 677-685.
110. Zhao, M.; Liu, Y.; Wang, X.; New, L.; Han, J.; Brunk, U. T. Activation Of The P38 MAP Kinase Pathway Is Required For Foam Cell Formation From Macrophages Exposed To Oxidized LDL. APMIS 2002, 110, 458-468.
111. Zester, A.; Grendinger, E.; Bengal, E. P38 Mitogen-Activated Protein Kinase Pathway Promotes Skeletal Muscle Differentiation. J. Biol. Chem. 1999, 274, 5193-5200.
112. Cuenda, A.; Cohen, P. Stress-Activated Protein Kinase-2/P38 And A Rapamycin-Sensitive Pathway Are Required For C2C12 Myogenesis. J. Biol. Chem. 1999, 274, 4341-4346.
113. Galbiati, F.; Volonte, D.; Engelman, J. A.; Schere, P. E.; Lisanti, M. Targeted Downregulation Of Caveolin-3 Is Sufficient To Inhibit Myotube Formation In Differentiating C2C12 Myoblasts. J. Biol. Chem. 1999, 274, 30315-30321.
114. Wu, Z.; Woodring, P. J.; Bhakta, K. S.; Tamura, K.; Wen, F.; Feramisco, J. R.; Karin, M.; Wang, J. Y. J.; Puri, P. L. P38 And Extracellular Signal-Regulated Kinases Regulate Myogenic Program In Multiple Steps. Mol. Cell. Biol. 2000, 20, 3951-3964.
115. Bergstom, D. A.; Penn, B. H.; Strand, A.; Perry, R. L. S.; Rudnicki, M. A.; Tapscott, S. J. Promoter-Specific Regulation Of Myod Binding And Signal Transduction Cooperate To Pattern Gene Expression. Mol. Cell. 2002, 9, 587-600.
116. Suelves, M.; Lluis, F.; Ruiz, V.; Nebreda, A. R.; Munoz-Canoves, P. Phosphorylation Of MRF4 Mediates Repression Of Specific Myogenic Genes. EMBO J 2004, 23, 365-375.
117. Khurana, A.; Dey, C. S. P38 MAPK Interacts With Actin And Modulates Filament Assembly During Skeletal Muscle Differentiation. Differen. 2003, 71, 42-50.
118. Cabane, C.; Englaro, W.; Yeow, K.; Ragno, M.; Derijard, B. Regulation Of Cdc12 Myogenic Terminal Differentiation By MKK3/P38α Pathway. Am. J. Physiol. 2003, 284, C658-C666.
119. Jones, N. C.; Tyner, K. J.; Nibarger, L.; Stanley, H. M.; Cornelison, D. D. W.; Fedorov, Y. V.; Olwin, B. B. The P38α/β MAPK Functions As A Molecular Switch To Activate The Quienscent Satellite Cell. J. Cell Biol. 2005, 169, 105-116.
120. Yu, M.; Blomstrand, E.; Chibalin, A. V.; Krook, A.; Zierath, J. R. Marathon Running Increases ERK1/2 And P38 MAP Kinase Signalling To Downstream Targets In Human Skeletal Muscle. J. Physiol. 2001, 536, 273-82.
121. Akimoto, T,; Pohnert, S. C.; Li, P.; Zhang, M.; Gumbs, C.; Rosenberg, P. B.; Williams, R. S.; Yan, Z. Exercise Stimulates Pgc-1 {Alpha} Transcription In Skeletal Muscle Through Activation Of The P38 MAPK Pathway. J. Biol. Chem. 2005, 280, 19587-19593.
122. Boppart, M. D.; Asp, S.; Wojtaszewski, J. F.; Fielding, R. A.; Mohr, T.; Goodyear, J. L. Marathon Running Transiently Increases C-Jun NH2-Terminal Kinase And P38 Activities In Human Skeletal Muscle. J. Physiol. 2000, 526: 663-669.
123. Puigserver, P.; Rhee, J.; Lin, J,; Wu, Z.; Yoon, J. C.; Krause, S.; Mootha, V. K.; Lowell, B. B.; Spiegelman, B. M. Cytokine Stimulation Of Energy Expenditure Through P38 MAP Kinase Activation Of Ppargamma Coactivator-1. Mol. Cell 2001, 8, 971-982.
124. Niu, W.; Huang, C.; Nawaz, Z.; Levy, M.; Somwar, R.; Li, D.; Bilan, P. J.; Klip, A. Maturation Of The Regulation Of GLUT4 Activity By P38 MAPK During L6 Cell Myogenesis. J. Biol. Chem. 2003, 278, 17953-17962.
125. Nader, G. A.; Esser, K. A. Intracellular Signaling Specificity In Skeletal Muscle In Response To Different Modes Of Exercise. J. Appl. Physiol. 2001, 90, 1936-1942.
126. Boppart, M. D.; Hirshmann, M. F.; Sakamoto, K.; Fielding, R. A.; Goodyear, L. J. Static Stretch Increases C-Jun NH2-Terminal Kinase Activity And P38 Phosphorylation In Rat Skeletal Muscle. Am. J. Physiol. 2001, 280: C352-C358.
127. Irrcher, I.; Adhihetty, P. J.; Sheehan, T.; Joseph, A. M.; Hood, D. A. Ppargamma Coactivator-1 alpha Expression During Thyroid Hormone- And Contractile Activity-Induced Mitochondrial Adaptations. Am. J. Physiol. 2003, 284, C1669-C1677.
128. Widegren, U.; Jiang, X. J.; Krook, A.; Chibalm, A. V.; Bjornholm, M.; Tally, M; Roth, R. A.; Henriksson, J.; Wallberg-Henriksonn, H.; Zeirath, J. R. Divergent Effects Of Exercise On Metabolic And Mitogenic Signaling Pathways In Human Skeletal Muscle. FASEB J. 1998, 12, 1379-1389.
129. s6k, And JNK2 Signaling Pathways In Skeletal Muscle. J. Appl. Physiol. 2005, 98, 1562-1566.
130. Aronson, D.; Wojtaszewski, J. F.; Thorell, A.; Nygren, J.; Zangen, D.; Richter, E. A.; Ljungqvist, O.; Fielding, R. A.; Goodyear, L. J. Extracellular-Regulated Protein Kinase Cascades Are Activated In Response To Injury In Human Skeletal Muscle. Am. J. Physiol. 1998, 275, C555-C561.
131. Uddin, S.; Ah-Kang, J.; Ulaszek, J.; Mahmud, D.; Wickrema, A. Differentiation Stage-Specific Activation Of P38 Mitogen-Activated Protein Kinase Isoforms In Primary Human Erythroid Cells. Proc. Natl. Acad. Sci. 2004, 101, 147-152.
132. Rausch, O.; Marshall, C. J. Cooperation Of P38 And Extracellular Signal-Related Kinase Mitogen-Activated Protein Kinase Pathways During Granulocyte Colony-Stimulating Factor-Induced Hematopoietic Cell Proliferation. J. Biol. Chem. 1999, 274, 4096-4105.
133. Lee, S. H.; Park, J.; Che, Y.; Han, P- L.; Lee, J- K. Constitutive Activity And Differential Localization Of P38α And P38β Mapks In Adult Mouse Brain. J. Neurosci. Res. 2000, 60, 623-631.
134. Zhen, X. C.; Cai, G. P.; Uryu, K.; Johnson, G. P.; Freidman, E. Age-Associated Impairment In Brain MAPK Signal Pathways And Effect Of Caloric Restriction In Fischer 344 Rats. J. Gerontol. 1999, 54, B539-B548.
135. Kyosseva, S. V.; Elbein, A. D.; Griffin, W. S.; Mrak, R. E.; Lyon, M.; Karson, C. N. 1999. Mitogen-Activated Protein Kinases In Schizophrenia. Biol. Psychiatry 1999, 46, 689-696.
136. Svensson, C. I.; Fitzsimmons, B.; Azizi, S.; Powell, H. C.; Hua, X. Y.; Yaksh, T. L. Spinal P38beta Isoform Mediates Tissue Injury-Induced Hyperalgesia And Spinal Sensitization. J. Neurochem. 2005, 92, 1508-1520.
137. Piao, C. S.; Che, Y.; Han, P. L.; Lee, J. K. Delayed And Differential Induction Of P38 MAPK Isoforms In Microglia And Astrocytes In The Brain After Transient Global Ischemia. Brain Res. Mol. Brain. Res. 2002, 107, 137-144.
138. Orchard, S. Kinases as Targets: Prospects for Chronic Therapy. Curr. Opin. Drug Disc. Develop. 2002, 5, 713-717.
139. Amakye, D.; Tong, S.; Ward, C.; Beazley, W. Pharmacokinetics (PK) and Pharmacodynamics (PD) of Scio-469, a p38 Alpha MAP Kinase Inhibitor. Clin. Pharmacol. Therapeut. 2004, 75, 54; Abstract PII-7.
140. Awad M. M.; Enslen H.; Boylan J. M.; Davis R. J.; Gruppuso P. A. Growth Regulation Via P38 Mitogen-Activated Protein Kinase In Developing Liver. J. Biol. Chem. 2000, 275, 38716-21.
141. Spector, M. S.; Auer, K. L.; Jarvis, W. D.; Ishac E. J.; Gao, B.; Kunos, G.; Dent P. Differential Regulation Of The Mitogen-Activated Protein And Stress-Activated Protein Kinase Cascades By Adrenergic Agonists In Quiescent And Regenerating Adult Rat Hepatocytes. Mol. Cell. Biol. 1997, 17, 3556-2565.
142. Liao, J. H.; Chen, J. S.; Chai, M. Q.; Zhao, S.; Song, J. G. The Involvement Of P38 MAPK In Transforming Growth Factor Beta1-Induced Apoptosis In Murine Hepatocytes. Cell Res. 2001, 11, 89-94.
143. R. Carini, R.; Albano, E. Recent Insights On The Mechanisms Of Liver Preconditioning. Gastroenterology 2003, 125, 1480-1491.
144. Yang, S. H.; Lee, C. G.; Lee, C. W.; Choi, E. J., Toon, S. K.; Ahn, K. S. Hepatitis C Virus Core Inhibits The Fas-Mediated P38 Mitogen Activated Kinase Signaling Pathway In Hepatocytes. Mol. Cell 2002, 13, 452-462.
145. Nagy, L. E. Recent Insights Into The Role Of The Innate Immune System In The Development Of Alcoholic Liver Disease. Exp. Biol. Med. 2003, 228, 882-890.